EUVIMEDEUVIMED entdecken
Fallbericht

A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment

Daniel Dulf, Paul Kubelak, Dana Iancu, Tudor-Eliade Ciuleanu

Journal of Medical and Radiation Oncology · 2021

DOI: 10.53011/jmro.2021.01.05 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Medical and Radiation Oncology, 2021. Verfasst von Daniel Dulf und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

"Metastatic non-small cell lung cancer has historically been associated with a poor prognosis. The introduction of targeted agents against certain molecules involved in cellular pathways has shown improved responses, but long-term survivors are still rare. We present the case of a patient with lung adenocarcinoma harboring sensitizing EGFR mutations who showed an impressive survival of more than 9 years following a combination of systemic therapies consisting of cytotoxic drugs and EGFR TKIs that were very well tolerated."

Zitieren

APA

Dulf, D., Kubelak, P., Iancu, D., & Ciuleanu, T. (2021). A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment. Journal of Medical and Radiation Oncology. https://doi.org/10.53011/jmro.2021.01.05

Vancouver

Dulf D, Kubelak P, Iancu D, Ciuleanu T. A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment. Journal of Medical and Radiation Oncology. 2021. doi:10.53011/jmro.2021.01.05

BibTeX
@article{Dulf2021,
  author = {Dulf, Daniel and Kubelak, Paul and Iancu, Dana and Ciuleanu, Tudor-Eliade},
  title = {A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment},
  journal = {Journal of Medical and Radiation Oncology},
  year = {2021},
  doi = {10.53011/jmro.2021.01.05}
}
Kostenlos starten →